Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus. 1988

K Taniguchi, and W L Maloy, and K Nishikawa, and K Y Green, and Y Hoshino, and S Urasawa, and A Z Kapikian, and R M Chanock, and M Gorziglia
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.

The group A rotaviruses are composed of at least seven serotypes. Serotype specificity is defined mainly by an outer capsid protein, VP7. In contrast, the other surface protein, VP3 (775 amino acids), appears to be associated with both serotype-specific and heterotypic immunity. To identify the cross-reactive and serotype-specific neutralization epitopes on VP3 of human rotavirus, we sequenced the VP3 gene of antigenic mutants resistant to each of seven anti-VP3 neutralizing monoclonal antibodies (N-MAbs) which exhibited heterotypic or serotype 2-specific reactivity, and we defined three distinct neutralization epitopes on VP3. The mutants sustained single amino acid substitutions at position 305, 392, 433, or 439. Amino acid position 305 was critical to epitope I, whereas amino acid position 433 was critical to epitope III. In contrast, epitope II appeared to be more dependent upon conformation and protein folding because both amino acid positions 392 and 439 appeared to be critical. These four positions clustered in a relatively limited area of VP5, the larger of the two cleavage products of VP3. At the positions where amino acid substitutions occurred, there was a correlation between amino acid sequence homology among different serotypes and the reactivity patterns of various viruses with the N-MAbs used for selection of mutants. A synthetic peptide (amino acids 296 to 313) which included the sequence of epitope I reacted with its corresponding N-MAb, suggesting that the region contains a sequential antigenic determinant. These data may prove useful in current efforts to develop vaccines against human rotavirus infection.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D002213 Capsid The outer protein protective shell of a virus, which protects the viral nucleic acid. Capsids are composed of repeating units (capsomers or capsomeres) of CAPSID PROTEINS which when assembled together form either an icosahedral or helical shape. Procapsid,Prohead,Capsids,Procapsids,Proheads
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

K Taniguchi, and W L Maloy, and K Nishikawa, and K Y Green, and Y Hoshino, and S Urasawa, and A Z Kapikian, and R M Chanock, and M Gorziglia
January 1991, Archives of virology,
K Taniguchi, and W L Maloy, and K Nishikawa, and K Y Green, and Y Hoshino, and S Urasawa, and A Z Kapikian, and R M Chanock, and M Gorziglia
May 1987, Journal of virology,
K Taniguchi, and W L Maloy, and K Nishikawa, and K Y Green, and Y Hoshino, and S Urasawa, and A Z Kapikian, and R M Chanock, and M Gorziglia
January 1996, Archives of virology,
K Taniguchi, and W L Maloy, and K Nishikawa, and K Y Green, and Y Hoshino, and S Urasawa, and A Z Kapikian, and R M Chanock, and M Gorziglia
January 1996, Archives of virology,
K Taniguchi, and W L Maloy, and K Nishikawa, and K Y Green, and Y Hoshino, and S Urasawa, and A Z Kapikian, and R M Chanock, and M Gorziglia
March 1991, Journal of clinical microbiology,
K Taniguchi, and W L Maloy, and K Nishikawa, and K Y Green, and Y Hoshino, and S Urasawa, and A Z Kapikian, and R M Chanock, and M Gorziglia
August 1989, Virology,
K Taniguchi, and W L Maloy, and K Nishikawa, and K Y Green, and Y Hoshino, and S Urasawa, and A Z Kapikian, and R M Chanock, and M Gorziglia
July 1995, Clinical and diagnostic laboratory immunology,
K Taniguchi, and W L Maloy, and K Nishikawa, and K Y Green, and Y Hoshino, and S Urasawa, and A Z Kapikian, and R M Chanock, and M Gorziglia
November 1990, The Journal of general virology,
K Taniguchi, and W L Maloy, and K Nishikawa, and K Y Green, and Y Hoshino, and S Urasawa, and A Z Kapikian, and R M Chanock, and M Gorziglia
January 1991, The Journal of general virology,
K Taniguchi, and W L Maloy, and K Nishikawa, and K Y Green, and Y Hoshino, and S Urasawa, and A Z Kapikian, and R M Chanock, and M Gorziglia
July 2008, Journal of virology,
Copied contents to your clipboard!